DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Durie BGM, Hoering A, Abidi MH. et al.
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
Lancet 2017;
389 (10/068) 519-527
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.